Cardiology Online - International Academy of Cardiology
 
»search site
The International Academy of Cardiology is dedicated to the advancement of global research in cardiovascular medicine through the support of scientific meetings and publications.
   Home Page
   Congresses
   Journals
   Organizations
   Institutions
   Books
   Research
   Guidelines
   Discussion Groups
   Webcourses
   Websites
   Job Opportunities
   Contact Us




 

 

 

 


21st World Congress on Heart Disease

 

IL-1 INDUCES CARDIAC ARRHYTHMIA IN DIABETES THROUGH ROS REGULATION



Samuel C. Dudley, M.D., Ph.D., Brown University, The Miriam and Rhode Island Hospitals, Providence, RI, USA

 

Background: Diabetes is associated with prolonged QT interval and high risk of sudden cardiac death. A recent publication shows that cardiac macrophage-derived IL-1 causes QTc prolongation and increases arrhythmic risk in diabetes. Nevertheless, how IL-1 signals arrhythmic risk is unclear.

Methods and results: C57BL/6J mice were fed with 60 kcal% high fat diet (HFD) for 20 weeks. In comparison to the control mice fed with low fat diet, APD (41115 ms vs. 615 ms, p<0.05) and QTc interval (50.6 1.8ms vs. 41.5 0.8 ms, p<0.05) were substantially prolonged, and the inducibility of ventricular arrhythmia was significantly higher, while the heart function was preserved. Underlying these electrophysiological changes were alterations in L-type calcium current and Ca2+ handling leading to spontaneous sarcoplasmic reticulum (SR) Ca2+ releases and early afterdepolarizations (EADs). Cardiac IL-1 was elevated accompanied with upregulated NOX4 and increased mitochondrial reactive oxygen species (mitoROS). Inhibiting IL-1 or mitoROS by treating HFD mice with an IL-1 receptor antagonist (IL-1RA) or mitoTEMPO, respectively, shortened QT interval and APD, reduced calcium sparks and EADs, demonstrating that these electrophysiological changes were mediated by IL-1 and mitoROS. Moreover, inhibiting IL-1 lowered NOX4 and mitoROS, suggesting IL-1 signaled arrhythmia through ROS modulation. Further study revealed increased oxidation of ryanodine receptor and phosphorylation of Calcium/calmodulin-dependent protein kinase II (CaMKII), which was reversed by IL-1RA treatment.

Conclusion: Diabetes associated electrophysiological changes and arrhythmic risk was mediated by IL-1. ROS, especially mitoROS, may provide a mechanistic link between IL-1 and DM associated arrhythmia.

 

 

©1998-2018 Cardiology Online, Inc. All rights reserved.
Cardiology Online is a registered trademark of Cardiology Online, Inc.
CardiologyOnline.com